Vaneck Pharmaceutical Etf ETF Forecast

Buy candidate since Jun 22, 2026

The VanEck Pharmaceutical ETF price gained 0.92% on the last trading day (Monday, 22nd Jun 2026), rising from $102.53 to $103.47. During the last trading day the ETF fluctuated 1.23% from a day low at $102.58 to a day high of $103.84. The price has fallen in 7 of the last 10 days and is down by -2.16% for this period. Volume fell on the last day by -604 thousand shares and in total, 221 thousand shares were bought and sold for approximately $22.87 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF lies in the middle of a weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 2.15% during the next 3 months and, with a 90% probability hold a price between $103.88 and $109.73 at the end of this 3-month period.

PPH Signals & Forecast

The VanEck Pharmaceutical ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $104.91. On a fall, the ETF will find some support from the long-term average at approximately $103.31. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 0.92%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The ETF should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for VanEck Pharmaceutical ETF

VanEck Pharmaceutical finds support from accumulated volume at $102.53 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this ETF. During the last day, the ETF moved $1.26 between high and low, or 1.23%. For the last week the ETF has had daily average volatility of 1.63%.

Our recommended stop-loss: $98.22 (-5.07%) (This ETF has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (PPH) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect VanEck Pharmaceutical ETF to open at $103.30, and during the day (based on 14 day Average True Range), to move between $102.60 and $104.34, which gives a possible trading interval of +/-$1.75 (+/-1.70%) up or down from last closing price. If VanEck Pharmaceutical ETF takes out the full calculated possible swing range there will be an estimated 1.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $103.88 (0.40%) than the support at $102.53 (0.91%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is VanEck Pharmaceutical ETF ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for VanEck Pharmaceutical ETF to perform well in the short-term. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Sell to a Buy candidate.

Current score: 3.842 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $103.30 ( 0.168%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk